The DOI matches its Crossref record; 535 of the 535 references it cites were found in a registry or an index.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Open accessAbstract
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627 · cited 1×
“4% of the population met lifetime criteria for subthreshold BD (4).”
BackgroundMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Global burden of disease in young people aged 10–24 years: a systematic analysis
Gore, F. M., Bloem, P. J., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., Sawyer, S. M., & Mathers, C. D. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60512-6 · Cited by 2,301 · cited 1×
“Presentation and diagnosis:Across the world, BD is the fourth leading cause of disability among adolescents (15–19 years) (217).”
BackgroundCipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Mockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 1×
“A two-week, crossover RCT assessing adjunctive ketamine infusion in patients with treatmentresistant bipolar depression identified a robust early antidepressant effect (within 40 min), with improvement remaining significant versus placebo through day three (level 2) (111).”
BackgroundEffectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Research works printed but not linked: 31
- 10.4088/JCP.10m06618 · doi:10.4088/jcp.10m06618
- American Psychiatric Association, 2011, DSM‐5 Development: Bipolar and Related Disorders
- Feifel D, 2011, A naturalistic, single‐blind comparison of rapid dose administration of divalproex ER versus quetiapine in patients with acute bipolar mania, Innov Clin Neurosci, 8, 29
- 10.1002/hup.870 · doi:10.1002/hup.870
- 10.1111/j.1742-1241.2009.02116.x · doi:10.1111/j.1742-1241.2009.02116.x
- 10.4088/JCP.v61n1208 · doi:10.4088/jcp.v61n1208
- 10.1177/0091270009347870 · doi:10.1177/0091270009347870
- 10.1016/S0924-9338(10)71430-9 · doi:10.1016/s0924-9338(10)71430-9
- 10.1097/YIC.0b013e328329b199 · doi:10.1097/yic.0b013e328329b199
- Knesevich M, 2009, The Efficacy and Tolerability of Cariprazine in Acute Mania Associated With Bipolar I Disorder: A Phase II Trial [Abstract NR1‐049]
- Pfizer Inc, 2010, 3‐Week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
- Kemp DE, 2010, Predictive value of early improvement in bipolar depression trials: a post‐hoc pooled analysis of two 8‐week aripiprazole studies, Psychopharmacol Bull, 43, 5
- Ketter T, 2011, Presented at 164th Ann Mtg American Psychiatric Association
- Loebel A, 2012, Lurasidone Adjunctive to Lithium or Valproate for the Treatment of Bipolar I Depression: Results of a 6‐Week, Double‐Blind, Placebo‐Controlled
- Pfizer Inc, 2009, A Six‐Week Study Evaluating the Efficacy and Safety of GEODON in Patients With a Diagnosis of Bipolar I Depression
- Pfizer Inc, 2009, A Six‐Week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression
- 10.3109/15622970903544638 · doi:10.3109/15622970903544638
- Li X, 2009, Drug Utilization of Pregnancy Category D or X Drugs Among Child‐Bearing Age Women With Depression or Bipolar Disorder in Medicaid [Abstract]
- Food and Drug Administration, 2011, Antipsychotic Drugs: Class Labeling Change—Treatment During Pregnancy and Potential Risk to Newborns
- Imaz ML, 2011, Obstetrical and neonatal outcomes following prenatal exposure to lithium, Bipolar Disord, 13, 56
- Chessick C, 2011, Sensitivity and specificity of the Mood Disorder Questionnaire in the perinatal population, Bipolar Disord, 13, 35
- American Psychiatric Association, 2012, DSM‐5 Proposed Revision: Disruptive Mood Dysregulation Disorder
- 10.1176/appi.ps.60.8.1098 · doi:10.1176/appi.ps.60.8.1098
- Evans‐Lacko SE, 2010, Evaluation of guideline‐concordant care for bipolar disorder among privately insured youth, Prim Care Companion J Clin Psychiatry, 12, e1
- 10.1001/jama.2009.1152 · doi:10.1001/jama.2009.1152
- Young AH, 2010, The efficacy of quetiapine monotherapy in bipolar II depression: combined data from the BOLDER and EMBOLDEN studies, Bipolar Disord, 12, 58
- Kemp DE, 2011, Long‐term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine, Bipolar Disord, 13, 60
- Burdick K, 2011, Cognitive enhancement in euthymic bipolar patients with pramipexole: a placebo‐controlled adjunctive trial, Bipolar Disord, 13, 33
- Food and Drug Administration, 2011, FDA Drug Safety Communication: Serious Allergic Reactions Reported With the Use of Saphris (Asenapine Maleate)
- Cazorla P, 2011, Incidence, onset, and duration of treatment emergent somnolence with asenapine in patients with schizophrenia or bipolar disorder, Bipolar Disord, 13, 34
- 10.2190/PM.39.4.h · doi:10.2190/pm.39.4.h
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationGrande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Long-acting injectable risperidone and ziprasidone have some support in the prevention of both manic and depressive episodes (Level II) (Yatham et al., 2009), and paliperidone has been trialled in the prevention of mania (Berwaerts et al.”
BackgroundGeddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770
Self-citationCipriani, A., Barbui, C., Salanti, G., Rendell, J., Brown, R., Stockton, S., Purgato, M., Spineli, L. M., Goodwin, G. M., & Geddes, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60873-8 · Cited by 631
The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013
Ferrari, A. J., Stockings, E., Khoo, J., Erskine, H. E., Degenhardt, L., Vos, T., & Whiteford, H. A. (2016) · Bipolar Disorders · doi:10.1111/bdi.12423 · Cited by 583
Milev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586
“CANMAT, in collaboration with the International Society for Bipolar Disorders, has published separate guidelines for bipolar disorder.(2) This section on ‘‘Neurostimulation Treatments’’ is 1 of 6 guidelines articles; other sections of the guidelines will expand on disease burden and principles of care, psychological t…”
BackgroundSelf-citationParikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Self-citationLithium side effects and toxicity: prevalence and management strategies
Gitlin, M. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0068-y · Cited by 531
Kennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Self-citationAntipsychotic medication in schizophrenia: a review
Lally, J., & MacCabe, J. H. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv017 · Cited by 513
Bipolar Disorder and Suicide: a Review
Miller, J. N., & Black, D. W. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-1130-0 · Cited by 456
Potential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Self-citationMobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality
Nicholas, J., Larsen, M. E., Proudfoot, J., & Christensen, H. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4581 · Cited by 438
“…should be performed at baseline, with on-going monitoring for weight changes and adverse effects of medication” Yatham et al, 2013, pp 29 [19] “Important that women with bipolar disorder receive education early in the course of illness about the effects of mood stabilizing and other…”
InfluentialLam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Self-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
Wasserman, D., Rihmer, Z., Rujescu, D., Sarchiapone, M., Sokolowski, M., Titelman, D., Zalsman, G., Zemishlany, Z., & Carli, V. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.06.003 · Cited by 390
Miura, T., Noma, H., Furukawa, T. A., Mitsuyasu, H., Tanaka, S., Stockton, S., Salanti, G., Motomura, K., Shimano-Katsuki, S., Leucht, S., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70314-1 · Cited by 364
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
Alda, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.4 · Cited by 315
Self-citationSajatovic, M., Strejilevich, S. A., Gildengers, A. G., Dols, A., Al Jurdi, R. K., Forester, B. P., Kessing, L. V., Beyer, J., Manes, F., Rej, S., et al. (2015) · Bipolar Disorders · doi:10.1111/bdi.12331 · Cited by 309
Lam, R. W., McIntosh, D., Wang, J., Enns, M. W., Kolivakis, T., Michalak, E. E., Sareen, J., Song, W.-Y., Kennedy, S. H., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659416 · Cited by 288
Self-citationPharmacological treatment of adult bipolar disorder
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0044-2 · Cited by 272
Quetiapine for acute bipolar depression: a systematic review and meta-analysis
Suttajit, S., Srisurapanont, M., Maneeton, N., & Maneeton, B. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s63779 · Cited by 255
Differential diagnosis of bipolar disorder and major depressive disorder
Hirschfeld, R. M. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70004-7 · Cited by 234
(2011) · doi:10.2165/11586970-000000000-00000 · Cited by 225
Bipolar depression: the clinical characteristics and unmet needs of a complex disorder
McIntyre, R. S., & Calabrese, J. R. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1636017 · Cited by 211
Self-citationLong-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders
Forte, A., Baldessarini, R. J., Tondo, L., Vázquez, G. H., Pompili, M., & Girardi, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.02.011 · Cited by 203
Schoeyen, H. K., Kessler, U., Andreassen, O. A., Auestad, B. H., Bergsholm, P., Malt, U. F., Morken, G., Oedegaard, K. J., & Vaaler, A. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13111517 · Cited by 197
Llorca, P. M., Abbar, M., Courtet, P., Guillaume, S., Lancrenon, S., & Samalin, L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-340 · Cited by 188
Van Dijk, S., Jeffrey, J., & Katz, M. R. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.054 · Cited by 181
Parikh, S. V., Segal, Z. V., Grigoriadis, S., Ravindran, A. V., Kennedy, S. H., Lam, R. W., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.042 · Cited by 183
Self-citationSchaffer, A., Isometsä, E. T., Tondo, L., Moreno, D. H., Sinyor, M., Kessing, L. V., Turecki, G., Weizman, A., Azorin, J.-M., Ha, K., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415594427 · Cited by 175
“In a similar vein, there are numerous available clinical treatment guidelines for the management of BD (Goodwin, 2009; Grunze et al., 2009, 2010; Yatham et al., 2013), but 1 Task Force on Suicide, The International Society for Bipolar Disorders (ISBD), Pittsburgh, PA, USA; Mood and Anxiety…”
MethodSelf-citationKishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Okuya, M., Mishima, K., & Iwata, N. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00946-6 · Cited by 169
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium
de Sousa, R. T., Zarate, C. A., Zanetti, M. V., Costa, A. C., Talib, L. L., Gattaz, W. F., & Machado-Vieira, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.11.011 · Cited by 169
Perugi, G., Medda, P., Toni, C., Mariani, M., Socci, C., & Mauri, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161017233642 · Cited by 167
Bahji, A., Hawken, E. R., Sepehry, A. A., Cabrera, C. A., & Vazquez, G. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12994 · Cited by 159
Malhi, G. S., Bell, E., Boyce, P., Bassett, D., Berk, M., Bryant, R., Gitlin, M., Hamilton, A., Hazell, P., Hopwood, M., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.13036 · Cited by 152
Self-citationMcGirr, A., Vöhringer, P. A., Ghaemi, S. N., Lam, R. W., & Yatham, L. N. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30264-4 · Cited by 149
Self-citationPharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
Dias, V. V., Balanzá‐Martinez, V., Soeiro‐de‐Souza, M. G., Moreno, R. A., Figueira, M. L., Machado‐Vieira, R., & Vieta, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01910.x · Cited by 146
Patten, S. B., Kennedy, S. H., Lam, R. W., O'Donovan, C., Filteau, M. J., Parikh, S. V., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.044 · Cited by 148
Self-citationKilbourne, A. M., Almirall, D., Eisenberg, D., Waxmonsky, J., Goodrich, D. E., Fortney, J. C., Kirchner, J. E., Solberg, L. I., Main, D., Bauer, M. S., et al. (2014) · Implementation Science · doi:10.1186/s13012-014-0132-x · Cited by 130
“For EBPs to reach these patients, effective implementation strategies are needed [31-34].”
BackgroundInfluentialCalabrese, J. R., Sanchez, R., Jin, N., Amatniek, J., Cox, K., Johnson, B., Perry, P., Hertel, P., Such, P., Salzman, P. M., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11201 · Cited by 135
Bond, D. J., Hadjipavlou, G., Lam, R. W., McIntyre, R. S., Beaulieu, S., Schaffer, A., & Weiss, M. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400104 · Cited by 133
Self-citationSelle, V., Schalkwijk, S., Vázquez, G., & Baldessarini, R. (2014) · Pharmacopsychiatry · doi:10.1055/s-0033-1363258 · Cited by 128
Clinical practice guidelines for management of bipolar disorder
Shah, N., Grover, S., & Rao, G. (2017) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.196974 · Cited by 124
Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357500 · Cited by 123
Self-citationBond, D. J., Lam, R. W., & Yatham, L. N. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.11.008 · Cited by 122
Self-citationHayes, J. F., Pitman, A., Marston, L., Walters, K., Geddes, J. R., King, M., & Osborn, D. P. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0432 · Cited by 121
Lindström, L., Lindström, E., Nilsson, M., & Höistad, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.012 · Cited by 122
Hayes, J. F., Marston, L., Walters, K., Geddes, J. R., King, M., & Osborn, D. P. J. (2016) · World Psychiatry · doi:10.1002/wps.20298 · Cited by 115
Antidepressants in bipolar depression: An enduring controversy
Gitlin, M. J. (2018) · International Journal of Bipolar Disorders · doi:10.1186/s40345-018-0133-9 · Cited by 116
Geddes, J. R., Gardiner, A., Rendell, J., Voysey, M., Tunbridge, E., Hinds, C., Yu, L.-M., Hainsworth, J., Attenburrow, M.-J., Simon, J., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00450-2 · Cited by 112
Ravindran, A. V., Lam, R. W., Filteau, M. J., Lespérance, F., Kennedy, S. H., Parikh, S. V., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.040 · Cited by 108
Self-citationCognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
Self-citationCastro, V. M., Roberson, A. M., McCoy, T. H., Wiste, A., Cagan, A., Smoller, J. W., Rosenbaum, J. F., Ostacher, M., & Perlis, R. H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.254 · Cited by 90
“US and international guidelines emphasize the importance of considering lithium treatment based on proven efficacy, understanding of long-term risks, and potential benefit in reducing liability for suicide (Goodwin et al, 2003; Yatham et al, 2005, 2013).”
BackgroundBipolar II postpartum depression: detection, diagnosis, and treatment
Sharma, V., Burt, V. K., & Ritchie, H. L. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121902 · Cited by 89
Self-citationRecording of Severe Mental Illness in United Kingdom Primary Care, 2000–2010
Hardoon, S., Hayes, J. F., Blackburn, R., Petersen, I., Walters, K., Nazareth, I., & Osborn, D. P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082365 · Cited by 90
Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90
Dols, A., Sienaert, P., van Gerven, H., Schouws, S., Stevens, A., Kupka, R., & Stek, M. L. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836435e2 · Cited by 86
Morriss, R., Lobban, F., Riste, L., Davies, L., Holland, F., Long, R., Lykomitrou, G., Peters, S., Roberts, C., Robinson, H., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30302-9 · Cited by 77
Nolen, W. A., & Weisler, R. H. (2013) · Bipolar Disorders · doi:10.1111/bdi.12027 · Cited by 73
Self-citationSuicidal Behavior in Mood Disorders: Response to Pharmacological Treatment
Tondo, L., & Baldessarini, R. J. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0715-0 · Cited by 71
Current psychotropic medication prescribing patterns in late‐life bipolar disorder
Rej, S., Herrmann, N., Shulman, K., Fischer, H. D., Fung, K., & Gruneir, A. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4635 · Cited by 69
“…whole province of Ontario from 2006 to 2012, prescribing practices in the post-discharge period often did not reflect bipolar treatment guidelines (Yatham et al., 2013) and were often potentially controversial; 4.4% of patients were using antidepressant monotherapy despite threefold risks of…”
BackgroundMethodInfluentialAltshuler, L. L., Sugar, C. A., McElroy, S. L., Calimlim, B., Gitlin, M., Keck, P. E., Aquino-Elias, A., Martens, B. E., Fischer, E. G., English, T. L., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15040558 · Cited by 68
Bipolar postpartum depression: An update and recommendations
Sharma, V., Doobay, M., & Baczynski, C. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.014 · Cited by 67
Self-citationYatham, L. N., Beaulieu, S., Schaffer, A., Kauer-Sant'Anna, M., Kapczinski, F., Lafer, B., Sharma, V, Parikh, S. V., Daigneault, A., Qian, H., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.158 · Cited by 64
Self-citationLi, H., Hong, W., Zhang, C., Wu, Z., Wang, Z., Yuan, C., Li, Z., Huang, J., Lin, Z., & Fang, Y. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.033 · Cited by 63
Parker, G. B., Graham, R. K., & Tavella, G. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12717 · Cited by 61
Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder
Grootens, K. P., Meijer, A., Hartong, E. G., Doornbos, B., Bakker, P. R., Al Hadithy, A., Hoogerheide, K. N., Overmeire, F., Marijnissen, R. M., & Ruhe, H. G. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2517-2 · Cited by 60
An update on antidepressant use in bipolar depression
Sidor, M. M., & MacQueen, G. M. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0323-6 · Cited by 57
Self-citationUnder-diagnosis of mood disorders in Canada
Pelletier, L., O'Donnell, S., Dykxhoorn, J., McRae, L., & Patten, S. B. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000329 · Cited by 57
Zhou, T.-H., Dang, W.-M., Ma, Y.-T., Hu, C.-Q., Wang, N., Zhang, G.-Y., Wang, G., Shi, C., Zhang, H., Guo, B., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.038 · Cited by 53
Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications
Marras, C., Herrmann, N., Fischer, H. D., Fung, K., Gruneir, A., Rochon, P. A., Rej, S., Vigod, S., Seitz, D., & Shulman, K. I. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.11.004 · Cited by 49
Kato, T., Ishigooka, J., Miyajima, M., Watabe, K., Fujimori, T., Masuda, T., Higuchi, T., & Vieta, E. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13137 · Cited by 49
Combination Therapy for Manic Phases: A Critical Review of a Common Practice
Geoffroy, P. A., Etain, B., Henry, C., & Bellivier, F. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12017 · Cited by 47
Muralidharan, K., Ali, M., Silveira, L. E., Bond, D. J., Fountoulakis, K. N., Lam, R. W., & Yatham, L. N. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.032 · Cited by 47
Self-citationPrevalence of Bipolar I and II Disorder in Canada
McDonald, K. C., Bulloch, A. G. M., Duffy, A., Bresee, L., Williams, J. V. A., Lavorato, D. H., & Patten, S. B. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000310 · Cited by 45
Sajatovic, M., Ross, R., Legacy, S. N., Correll, C. U., Kane, J. M., DiBiasi, F., Fitzgerald, H., & Byerly, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s167394 · Cited by 44
“18,19 It is not clear how newer LAIs should be incorporated or considered in the context of existing guidelines that place LAIs as most appropriate for a relatively narrow subgroup of patients with schizophrenia/schizoaffective or bipolar disorder.”
BackgroundValvassori, S. S., Dal-Pont, G. C., Steckert, A. V., Varela, R. B., Lopes-Borges, J., Mariot, E., Resende, W. R., Arent, C. O., Carvalho, A. F., & Quevedo, J. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.017 · Cited by 44
Bourin, M. S., Severus, E., Schronen, J. P., Gass, P., Szamosi, J., Eriksson, H., & Chandrashekar, H. (2014) · International Journal of Bipolar Disorders · doi:10.1186/s40345-014-0014-9 · Cited by 40
Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
Fancy, F., Rodrigues, N. B., Di Vincenzo, J. D., Chau, E. H., Sethi, R., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13284 · Cited by 40
Self-citationDropout rate and associated factors in patients with bipolar disorders
Moon, E., Chang, J. S., Kim, M. Y., Seo, M. H., Cha, B., Ha, T. H., Choi, S., Cho, H. S., Park, T., & Ha, K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.025 · Cited by 40
Self-citationDopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis
Szmulewicz, A. G., Angriman, F., Samamé, C., Ferraris, A., Vigo, D., & Strejilevich, S. A. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12712 · Cited by 37
Do, A., Li, V. W., Huang, S., Michalak, E. E., Tam, E. M., Chakrabarty, T., Yatham, L. N., & Lam, R. W. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221097903 · Cited by 37
Self-citationWang, S., Zhang, Z., Yao, L., Ding, N., Jiang, L., & Wu, Y. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232798 · Cited by 35
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
Young, A. H., Calabrese, J. R., Gustafsson, U., Berk, M., McElroy, S. L., Thase, M. E., Suppes, T., & Earley, W. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-10 · Cited by 35
Self-citationDatto, C., Pottorf, W. J., Feeley, L., LaPorte, S., & Liss, C. (2016) · Annals of General Psychiatry · doi:10.1186/s12991-016-0096-0 · Cited by 32
Rej, S., Elie, D., Mucsi, I., Looper, K. J., & Segal, M. (2015) · Drugs & Aging · doi:10.1007/s40266-014-0234-9 · Cited by 31
Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder
Parikh, S. V., Hawke, L. D., Velyvis, V., Zaretsky, A., Beaulieu, S., Patelis‐Siotis, I., MacQueen, G., Young, L. T., Yatham, L. N., & Cervantes, P. (2015) · Bipolar Disorders · doi:10.1111/bdi.12233 · Cited by 31
Self-citationUse of adjunctive stimulants in adult bipolar depression
Dell'Osso, B., & Ketter, T. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000326 · Cited by 31
Nery, F. G., Li, W., DelBello, M. P., & Welge, J. A. (2021) · Bipolar Disorders · doi:10.1111/bdi.13039 · Cited by 29
Szmulewicz, A., Samamé, C., Caravotta, P., Martino, D. J., Igoa, A., Hidalgo-Mazzei, D., Colom, F., & Strejilevich, S. A. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0047-3 · Cited by 28
Ramirez-Mahaluf, J. P., Rozas-Serri, E., Ivanovic-Zuvic, F., Risco, L., & Vöhringer, P. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00070 · Cited by 28
Holmes, S. E., Asch, R. H., Davis, M. T., DellaGioia, N., Pashankar, N., Gallezot, J.-D., Nabulsi, N., Matuskey, D., Sanacora, G., Carson, R. E., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.10.018 · Cited by 27
Medeiros, G. C., Lafer, B., Kapczinski, F., Miranda-Scippa, Â., & Almeida, K. M. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.12.003 · Cited by 23
Self-citationAttitudes towards pharmacotherapy in late-life bipolar disorder
Rej, S., Schuurmans, J., Elie, D., Stek, M. L., Shulman, K., & Dols, A. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215002380 · Cited by 23
Lithium Treatment in Children and Adolescents
Duffy, A., & Grof, P. (2018) · Pharmacopsychiatry · doi:10.1055/a-0575-4179 · Cited by 22
Metadata
- Authors
- Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., Young, L. T., Milev, R., Bond, D. J., Frey, B. N., Goldstein, B. I., Lafer, B., Birmaher, B., Ha, K., Nolen, W. A., & Berk, M.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2012-12-12
- Volume
- 15
- Issue
- 1
- Pages
- 1-44
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W1969114959
- Cited by
- 1,217
- References
- 535
- FWCI
- 85.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.